Novartis Loses Bid For Jury Trial In Famvir Patent Suit
A federal judge on Tuesday denied Novartis Pharmaceuticals Corp.'s bid for a jury trial in a patent infringement suit against Roxane Laboratories Inc. over herpes treatment Famvir, though the judge refused...To view the full article, register now.
Already a subscriber? Click here to view full article